Ausgabe 8/2019
Inhalt (15 Artikel)
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection
Zheng-Jun Zhou, Hao-Yang Xin, Jia Li, Zhi-Qiang Hu, Chu-Bin Luo, Shao-Lai Zhou
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Nadia Mensali, Marit Renée Myhre, Pierre Dillard, Sylvie Pollmann, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, Else Marit Inderberg
Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1)
Despoina Koumantou, Eilon Barnea, Adrian Martin-Esteban, Zachary Maben, Athanasios Papakyriakou, Anastasia Mpakali, Paraskevi Kokkala, Harris Pratsinis, Dimitris Georgiadis, Lawrence J. Stern, Arie Admon, Efstratios Stratikos
High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer
Timo Carpén, Timo Sorsa, Lauri Jouhi, Taina Tervahartiala, Caj Haglund, Stina Syrjänen, Jussi Tarkkanen, Hesham Mohamed, Antti Mäkitie, Jaana Hagström, Petri S. Mattila
Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model
Eiichi Ishida, Jina Lee, Jean S. Campbell, Patrick D. Chakravarty, Yukio Katori, Takenori Ogawa, Lauren Johnson, Anandaroop Mukhopadhyay, William C. Faquin, Derrick T. Lin, Lori J. Wirth, Robert H. Pierce, Sara I. Pai
Reduced CTL motility and activity in avascular tumor areas
Yoav Manaster, Zohar Shipony, Anat Hutzler, Masha Kolesnikov, Camila Avivi, Bruria Shalmon, Iris Barshack, Michal J. Besser, Tali Feferman, Guy Shakhar
Mouse CD8+NKT-like cells exert dual cytotoxicity against mouse tumor cells and myeloid-derived suppressor cells
Zhengyuan Li, Yiqing Wu, Chao Wang, Minghui Zhang
Interferon beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligand
Anna Makowska, Sabrina Franzen, Till Braunschweig, Bernd Denecke, Lian Shen, Valentin Baloche, Pierre Busson, Udo Kontny
Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade
Jun Zhou, Jingjing Li, Indira Guleria, Tianqi Chen, Anita Giobbie-Hurder, Jonathan Stevens, Meghna Gupta, Xinqi Wu, Ryan C. Brennick, Michael P. Manos, F. Stephen Hodi
Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells
Shinya Urakawa, Makoto Yamasaki, Kumiko Goto, Miya Haruna, Michinari Hirata, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Tomoki Makino, Yukinori Kurokawa, Tomomi Yamada, Masaki Mori, Yuichiro Doki, Hisashi Wada
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study
Aldo Bonaventura, Francesco Grossi, Federico Carbone, Alessandra Vecchié, Silvia Minetti, Nicholas Bardi, Edoardo Elia, Anna Maria Ansaldo, Daniele Ferrara, Erika Rijavec, Maria Giovanna Dal Bello, Giovanni Rossi, Federica Biello, Marco Tagliamento, Angela Alama, Simona Coco, Paolo Spallarossa, Franco Dallegri, Carlo Genova, Fabrizio Montecucco
CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro
Sandra Rosskopf, Judith Leitner, Gerhard J. Zlabinger, Peter Steinberger
Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy
Meng-Xin Tian, Yu-Fu Zhou, Wei-Feng Qu, Wei-Ren Liu, Lei Jin, Xi-Fei Jiang, Han Wang, Chen-Yang Tao, Pei-Yun Zhou, Yuan Fang, Zhen-Bin Ding, Yuan-Fei Peng, Jian Zhou, Jia Fan, Ying-Hong Shi
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck
Ashley Pinette, Elizabeth McMichael, Nicholas B. Courtney, Megan Duggan, Brooke N. Benner, Fouad Choueiry, Lianbo Yu, David Abood, Thomas A. Mace, William E. Carson III
4th Symposium on Advances in Cancer Immunology and Immunotherapy, November 29–December 1, 2018, Athens, Greece
Sotirios P. Fortis, Athanasios Kotsakis, Christophe Le Tourneau, Ourania E. Tsitsilonis, Vassilis Georgoulias, Constantin N. Baxevanis